CoreMap
Transforming treatment by getting to the heart of the problem
United States · Founded 2016 · $37.0M raised
- Founded
- 2016
- Business Model
- B2B
- Website
- coremapmedical.com
- Total Funding
- $37.0M
- Last Round
- $37.0M Series CJul 2026
- Rounds
- 1
About
CoreMap develops medical technology to map the electrical patterns underlying atrial fibrillation and support patient-specific ablation treatment. Its platform is intended to help electrophysiologists identify the mechanisms sustaining complex arrhythmias, with the goal of improving the effectiveness of curative therapy. The company is advancing its EP Mapping system through clinical development.
Summary
CoreMap is a Healthcare company based in United States, founded in 2016. It has raised $37.0M in total across 1 round, most recently a $37.0M Series C round in Jul 2026. Investors include Medtronic.
Funding History
Jul 2026
Investors
Similar Companies

operates in the healthcare industry focusing on biotechnology business
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer